Mark Diamond

Mark Diamond

Presidente en DIMERIX LIMITED .
Health Technology
Consumer Services
Distribution Services

Perfil

Mark Diamond is currently Non-Executive Chairman at Dimerix Ltd. since 2023 and Non-Executive Director at Arovella Therapeutics Ltd. starting in 2026.
Former roles include Chief Executive Officer & Executive Director at Percheron Therapeutics Ltd. from 2010 to 2023, Director-Project Planning & Business Development at Alpharma Specialty Pharma LLC, Manager-International Business Development at FH Faulding & Co. Ltd., and Senior Manager-Business Development at Faulding Pharmaceuticals Plc.
Education includes an undergraduate degree from Monash University and an MBA from Macquarie University.

Cargos activos de Mark Diamond

EmpresasCargoInicio
DIMERIX LIMITED Presidente 12/01/2023
AROVELLA THERAPEUTICS LIMITED Director/Miembro de la Junta 28/04/2026

Antiguos cargos conocidos de Mark Diamond.

EmpresasCargoFin
PERCHERON THERAPEUTICS LIMITED Director Ejecutivo 12/05/2023
Corporate Officer/Principal -
Faulding Pharmaceuticals Plc
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Mark Diamond.

Formación de Mark Diamond.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

38

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Faulding Pharmaceuticals Plc